Metabolife Ordered to Pay in Ephedra Suit
From Bloomberg News
Metabolife International Inc. was ordered to pay $4.07 million to four people who suffered heart attacks and strokes after they took the company’s Metabolife 365 diet supplement, which contains ephedra.
A federal jury in Birmingham, Ala., found the San Diego-based company’s weight-loss pill caused heart attacks, strokes, seizures and irregular heartbeats, lawyers for the plaintiffs said.
Officials at Metabolife said they intend to appeal the verdict.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
